Bihua Chen insider trades

Open-market stock purchases and sales by Bihua Chen, Unknown at BlossomHill Therapeutics, Inc, from SEC Form 4 filings since Oct 22, 2020.

Track record: 7% of 43 scored buys are up 5% or more since purchase, averaging -54%.

Recent trades

DateStockTradeValue
Aug 10, 2026BLSM BlossomHill Therapeutics, IncBought (not open market)—
Aug 10, 2026BLSM BlossomHill Therapeutics, IncBought (not open market)—
Aug 10, 2026BLSM BlossomHill Therapeutics, IncBought$5M
Aug 10, 2026BLSM BlossomHill Therapeutics, IncBought (not open market)—
Aug 10, 2026BLSM BlossomHill Therapeutics, IncBought (not open market)—
Aug 6, 2026BLSM BlossomHill Therapeutics, IncBought (not open market)—
Jul 1, 2026BBOT BridgeBio Oncology Therapeutics, IncSold (not open market)—
Jul 1, 2026BBOT BridgeBio Oncology Therapeutics, IncBought (not open market)—
Jul 1, 2026BBOT BridgeBio Oncology Therapeutics, IncBought (not open market)—
Jul 1, 2026BBOT BridgeBio Oncology Therapeutics, IncBought (not open market)—
Jun 16, 2026BBOT BridgeBio Oncology Therapeutics, IncBought (not open market)—
Jan 26, 2026HLXC Helix Acquisition Corp IIIBought (not open market)$5M
Jan 26, 2026HLXC Helix Acquisition Corp IIIBought (not open market)$5M
Jan 26, 2026HLXC Helix Acquisition Corp IIIBought$8M
Jan 22, 2026HLXC Helix Acquisition Corp IIIBought (not open market)—
Jan 22, 2026HLXC Helix Acquisition Corp IIIBought (not open market)—

Companies traded

  • BLSM BlossomHill Therapeutics, Inc: 1 buy, last Aug 10, 2026
  • BBOT BridgeBio Oncology Therapeutics, Inc: other filings, last Jul 1, 2026
  • HLXC Helix Acquisition Corp III: 1 buy, last Jan 26, 2026
  • MLTX MoonLake Immunotherapeutics: 37 buys, 5 sales, last Sep 30, 2025
  • BMEA Biomea Fusion, Inc: 2 buys, last Jun 11, 2025
  • HLXB Helix Acquisition Corp II: 3 buys, last Feb 8, 2025
  • ERAS Erasca, Inc: 4 buys, 1 sale, last Jun 22, 2023
  • HLXA Helix Acquisition Corp: 1 buy, last Oct 22, 2020

Get free alerts when Bihua Chen files a new trade →